View in EDS PDF Full Text

Endothelin-converting enzyme-1 is expressed in human cerebral cortex and protects against Alzheimer's disease.

Saved in:
Bibliographic Details
Title: Endothelin-converting enzyme-1 is expressed in human cerebral cortex and protects against Alzheimer's disease.
Authors: Funalot, B., Ouimet, T., Claperon, A., Fallet, C., Delacourte, A., Epelbaum, J., Subkowski, T., Léonard, N., Codron, V., David, J.-P., Amouyel, P., Schwartz, J.-C., Helbecque, N.
Source: Molecular Psychiatry. Dec2004, Vol. 9 Issue 12, p1122-1128. 7p.
Subjects: Enzymes, Endothelins, Enzymology, Alzheimer's disease, Psychiatry, Behavioral medicine
Abstract: Cerebral accumulation ofß-amyloid peptide (Aß) is a central event in the pathogenesis of Alzheimer's disease (AD). Endothelin-converting enzyme-1 (ECE-1) is a candidate Aß-degrading enzyme in brain, but its involvement in AD pathogenesis was never assessed. We first performed brain immunocytochemistry, using a monoclonal anti-ECE-1 antibody, and observed neuronal ECE-1 expression in various cortical regions of nondemented subjects. In the hippocampus, ECE-1 immunoreactivity showed a stereotypical pattern inversely correlated with susceptibility to Aßdeposition, further suggesting a physiological role in Aßclearance. In order to undertake a genetic association study, we identified a functional genetic variant (ECE1B C-338A) located in a regulatory region of the ECE1 gene. We showed that the A allele is associated with increased transcriptional activity in promoter-reporter gene assays and with increased ECE-1 mRNA expression in human neocortex. In a case-control study involving 401 patients with late-onset AD and 461 aged controls, we found that homozygous carriers of the A allele had a reduced risk of AD (OR=0.47, 95%CI 0.25-0.88). This finding was strengthened by the analysis of two other genetic variants of the ECE1 gene, which showed that the genetic association is extended over at least 13 kilobases of the gene sequence. Our results suggest that ECE-1 expression in brain may be critical for cortical Aßclearance and offer new potential targets for therapeutic interventions in AD.Molecular Psychiatry (2004) 9, 1122-1128. doi:10.1038/sj.mp.4001584 Published online 31 August 2004 [ABSTRACT FROM AUTHOR]
Copyright of Molecular Psychiatry is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Psychology and Behavioral Sciences Collection
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: pbh
DbLabel: Psychology and Behavioral Sciences Collection
An: 15109657
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Endothelin-converting enzyme-1 is expressed in human cerebral cortex and protects against Alzheimer's disease.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Funalot%2C+B%2E%22">Funalot, B.</searchLink><br /><searchLink fieldCode="AR" term="%22Ouimet%2C+T%2E%22">Ouimet, T.</searchLink><br /><searchLink fieldCode="AR" term="%22Claperon%2C+A%2E%22">Claperon, A.</searchLink><br /><searchLink fieldCode="AR" term="%22Fallet%2C+C%2E%22">Fallet, C.</searchLink><br /><searchLink fieldCode="AR" term="%22Delacourte%2C+A%2E%22">Delacourte, A.</searchLink><br /><searchLink fieldCode="AR" term="%22Epelbaum%2C+J%2E%22">Epelbaum, J.</searchLink><br /><searchLink fieldCode="AR" term="%22Subkowski%2C+T%2E%22">Subkowski, T.</searchLink><br /><searchLink fieldCode="AR" term="%22Léonard%2C+N%2E%22">Léonard, N.</searchLink><br /><searchLink fieldCode="AR" term="%22Codron%2C+V%2E%22">Codron, V.</searchLink><br /><searchLink fieldCode="AR" term="%22David%2C+J%2E-P%2E%22">David, J.-P.</searchLink><br /><searchLink fieldCode="AR" term="%22Amouyel%2C+P%2E%22">Amouyel, P.</searchLink><br /><searchLink fieldCode="AR" term="%22Schwartz%2C+J%2E-C%2E%22">Schwartz, J.-C.</searchLink><br /><searchLink fieldCode="AR" term="%22Helbecque%2C+N%2E%22">Helbecque, N.</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Molecular+Psychiatry%22">Molecular Psychiatry</searchLink>. Dec2004, Vol. 9 Issue 12, p1122-1128. 7p.
– Name: Subject
  Label: Subjects
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22Enzymes%22">Enzymes</searchLink><br /><searchLink fieldCode="DE" term="%22Endothelins%22">Endothelins</searchLink><br /><searchLink fieldCode="DE" term="%22Enzymology%22">Enzymology</searchLink><br /><searchLink fieldCode="DE" term="%22Alzheimer's+disease%22">Alzheimer's disease</searchLink><br /><searchLink fieldCode="DE" term="%22Psychiatry%22">Psychiatry</searchLink><br /><searchLink fieldCode="DE" term="%22Behavioral+medicine%22">Behavioral medicine</searchLink>
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: Cerebral accumulation ofß-amyloid peptide (Aß) is a central event in the pathogenesis of Alzheimer's disease (AD). Endothelin-converting enzyme-1 (ECE-1) is a candidate Aß-degrading enzyme in brain, but its involvement in AD pathogenesis was never assessed. We first performed brain immunocytochemistry, using a monoclonal anti-ECE-1 antibody, and observed neuronal ECE-1 expression in various cortical regions of nondemented subjects. In the hippocampus, ECE-1 immunoreactivity showed a stereotypical pattern inversely correlated with susceptibility to Aßdeposition, further suggesting a physiological role in Aßclearance. In order to undertake a genetic association study, we identified a functional genetic variant (ECE1B C-338A) located in a regulatory region of the ECE1 gene. We showed that the A allele is associated with increased transcriptional activity in promoter-reporter gene assays and with increased ECE-1 mRNA expression in human neocortex. In a case-control study involving 401 patients with late-onset AD and 461 aged controls, we found that homozygous carriers of the A allele had a reduced risk of AD (OR=0.47, 95%CI 0.25-0.88). This finding was strengthened by the analysis of two other genetic variants of the ECE1 gene, which showed that the genetic association is extended over at least 13 kilobases of the gene sequence. Our results suggest that ECE-1 expression in brain may be critical for cortical Aßclearance and offer new potential targets for therapeutic interventions in AD.Molecular Psychiatry (2004) 9, 1122-1128. doi:10.1038/sj.mp.4001584 Published online 31 August 2004 [ABSTRACT FROM AUTHOR]
– Name: AbstractSuppliedCopyright
  Label:
  Group: Ab
  Data: <i>Copyright of Molecular Psychiatry is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.)
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=15109657
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/sj.mp.4001584
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 7
        StartPage: 1122
    Subjects:
      – SubjectFull: Enzymes
        Type: general
      – SubjectFull: Endothelins
        Type: general
      – SubjectFull: Enzymology
        Type: general
      – SubjectFull: Alzheimer's disease
        Type: general
      – SubjectFull: Psychiatry
        Type: general
      – SubjectFull: Behavioral medicine
        Type: general
    Titles:
      – TitleFull: Endothelin-converting enzyme-1 is expressed in human cerebral cortex and protects against Alzheimer's disease.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Funalot, B.
      – PersonEntity:
          Name:
            NameFull: Ouimet, T.
      – PersonEntity:
          Name:
            NameFull: Claperon, A.
      – PersonEntity:
          Name:
            NameFull: Fallet, C.
      – PersonEntity:
          Name:
            NameFull: Delacourte, A.
      – PersonEntity:
          Name:
            NameFull: Epelbaum, J.
      – PersonEntity:
          Name:
            NameFull: Subkowski, T.
      – PersonEntity:
          Name:
            NameFull: Léonard, N.
      – PersonEntity:
          Name:
            NameFull: Codron, V.
      – PersonEntity:
          Name:
            NameFull: David, J.-P.
      – PersonEntity:
          Name:
            NameFull: Amouyel, P.
      – PersonEntity:
          Name:
            NameFull: Schwartz, J.-C.
      – PersonEntity:
          Name:
            NameFull: Helbecque, N.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 12
              Text: Dec2004
              Type: published
              Y: 2004
          Identifiers:
            – Type: issn-print
              Value: 13594184
          Numbering:
            – Type: volume
              Value: 9
            – Type: issue
              Value: 12
          Titles:
            – TitleFull: Molecular Psychiatry
              Type: main
ResultId 1